1 |
K.C. Hayes, M.A. Katz, J.G. Devane, J.T.C. Hsieh, D.L. Wolfe, P.J. Porter and A. R. Blight, Pharmacokinetics of an immediate-release oral formulation of fampridine (4- Aminopyridine) in normal subjects and patients with spinal cord injury, J. Clin. Pharmacol., 43, 379-385 (2003)
DOI
ScienceOn
|
2 |
Y. Qiu, K. Flood, K. Marsh, S. Caroll, J. Trivedi, S.P. Americ and S.L. Krill, Design of sustained-release matrlx systems for a highly water-soluble compound, ABT-089, Int. J. Pharm., 157, 43-52 (1997)
DOI
ScienceOn
|
3 |
P. Costa and J.M. Sausa Lobo, Modeling and comparison of dissolution profiles Eur. J. Pharm, Sci., 13, 123-133 (2001)
DOI
ScienceOn
|
4 |
J. Siepmann and N.A. Peppas, Modeling of drug release from delivery systems based on hydroxypropyl methyl-cellulose(HMPC), Adv. Drug Deliv. Rev. 48, 139-157 (2001)
DOI
ScienceOn
|
5 |
P.L. Ritger and N.A. Peppas, A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices, J. Controll. ReI., 5, 37-42 (1987)
DOI
ScienceOn
|
6 |
C. Alison, C. Hodsdon, J.R. Mitchell, M.C. Davies and C.D. Melia, Structure and behaviour in hydrophilic matrix sustained release dosage forms: 3. The influence of pH on the sustained-release performance and internal gel structure of sodium alginate matrices, J. Controll. ReI., 33, 143-152 (1995)
DOI
ScienceOn
|
7 |
J. Evenhuis, S. Agoston, P.J. Salt, AR. de Lange, W. Wouthuyzen and W. Erdmann, Pharmacokinetics of 4-aminopyridine in human volunteers. A preliminary study using a new GLC method for its estimation, Br. J. Anaesth., 53, 567-570 (1981)
DOI
ScienceOn
|
8 |
H. Juarez, G. Rico and L. Villafuerte, Influence of admixed carboxymethylcellulose on reIease of 4-aminopyridine from hydroxypropyl methylcellulose matrix tablets, Int. J. Pharm., 216, 115-125 (2001)
DOI
ScienceOn
|
9 |
N.K. Ebube and A.B. Jones, Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers, Int. J. Pharm., 272, 19-27 (2004)
DOI
ScienceOn
|
10 |
E.Y. Yi, S.Y. Park, U.K. Jee and D.C. Kim, Pharmaceutical formulation and evaluation of sustained-release hydrophilic matrix tablet of cefatrizine propyleneglycol using polyethylene oxide, J. Kor.Pharm. Sci., 31, 37-41 (2001)
|
11 |
M.M. Talukdar and R. Kinget, Swelling and drug release behaviour of xanthan gum matrix tablets, Int. J. Pharm., 120, 63-72(1995)
DOI
ScienceOn
|
12 |
J.L. Segal and S.R. Brunnemann, 4-Aminopyridine improves pulmonary function in quadriplegic humans with longstanding spinal cord injury, Pharmacotherapy, 17, 415-423 (1997)
|
13 |
C. Van der Veen, H. Buitendijk and C.P. Lerk, The effect of acidic excipients on the release of weakly basic drugs from the programmed release megaloporous system, Eur. J. Pharm. Biopharm., 37, 238-242 (1991)
|
14 |
K.C. Hayes, P.J. Potter, J.T. Hsieh, M.A. Katz, A.R. Blight and R. Cohen, Pharmacokinetics and sailety of multiple oral doses of sustained-release 4-aminopyridine (fampridine-sr) in subjects with chronic, incomplete spinal cord injury, Arch Phys. Med. Rehabil., 85, 29-34 (2004)
DOI
ScienceOn
|
15 |
M. Davidson, Z. Zemishlany, R.C. Mohs, T.B. Horvath, P. Powchik, J.P. Blass and K.L. Davis, 4-Aminopyridine in the treatment of Alzheimer's disease, BioI. Psychiatry, 23, 485-490 (1988)
DOI
ScienceOn
|
16 |
F.A. Davis, D. Stefoski and J. Rush, Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis, Ann. Neurol., 27, 186-192 (1990)
DOI
ScienceOn
|